The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
VIR Combination
Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex I, Herpes Simplex II Nosode, Human Herpesvirus 6A, Influenzinum · HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL; HUMAN HERPESVIRUS 5 18 [hp_X]/mL; HERRING SPERM DNA 12 [hp_X]/mL; HUMAN HERPESVIRUS 4 16 [hp_C]/mL; HEPATITIS B VIRUS 33 [hp_X]/mL; HUMAN HERPESVIRUS 1 15 [hp_X]/mL; HUMAN HERPESVIRUS 2 15 [hp_X]/mL; HUMAN HERPESVIRUS 6 15 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 12 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 12 [hp_C]/mL · Liquid · Oral · Deseret Biologicals, Inc.
NDC 43742-2357-01 · 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex I, Herpes Simplex II Nosode, Human Herpesvirus 6A, Influenzinum (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Deseret Biologicals, Inc. | HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL; HUMAN HERPESVIRUS 5 18 [hp_X]/mL; HERRING SPERM DNA 12 [hp_X]/mL; HUMAN HERPESVIRUS 4 16 [hp_C]/mL; HEPATITIS B VIRUS 33 [hp_X]/mL; HUMAN HERPESVIRUS 1 15 [hp_X]/mL; HUMAN HERPESVIRUS 2 15 [hp_X]/mL; HUMAN HERPESVIRUS 6 15 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 12 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 12 [hp_C]/mL | Aug 26, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 33 [hp_X]/mL; HUMAN HERPESVIRUS 5 12 [hp_X]/mL; HERRING SPERM DNA 12 [hp_C]/mL; HUMAN HERPESVIRUS 4 15 [hp_X]/mL; HEPATITIS B VIRUS 15 [hp_X]/mL; HUMAN HERPESVIRUS 1 16 [hp_C]/mL; HUMAN HERPESVIRUS 2 18 [hp_X]/mL; HUMAN HERPESVIRUS 6 15 [hp_X]/mL; INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 12 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 12 [hp_C]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Deseret Biologicals, Inc. | HEPATITIS B VIRUS 33 [hp_X]/mL; HERRING SPERM DNA 12 [hp_X]/mL; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL; HUMAN HERPESVIRUS 1 15 [hp_X]/mL; HUMAN HERPESVIRUS 2 15 [hp_X]/mL; HUMAN HERPESVIRUS 4 16 [hp_C]/mL; HUMAN HERPESVIRUS 5 18 [hp_X]/mL; HUMAN HERPESVIRUS 6 15 [hp_X]/mL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL; INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 12 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 12 [hp_C]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "VIR Combination — NDC 43742-2357-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43742235701.
Free to cite with attribution — see how the data is put together.